Vaccines Market by Technology, Disease Indication, End User & Type - 2021 | MarketsandMarkets

1
MarketsandMarkets Presents
Vaccines Technology Market worth 48.03 Billion
USD by 2021
2

• The global vaccines market is expected to reach
  48.03 Billion by 2021 from USD 32.24 Billion in
  2016 at a CAGR of 8.3. The global market is
  broadly classified into technology, type, disease
  indication, end-users, and regions.
• On the basis of technology, the vaccines market
  is segmented into conjugate vaccines, inactivated
  and subunit vaccines, live attenuated vaccines,
  toxoid vaccines, and recombinant vaccines. The
  conjugate vaccines segment is expected to account
  for the largest share of the global market in
  2016. Increasing government support for vaccine
  development and rising company investments will
  drive the growth of this market segment.
• Early buyers will receive 10 customization on
  reports.

3

• Based on type, the vaccines market is segmented
  into monovalent vaccines and multivalent
  vaccines. The monovalent vaccines segment is
  expected to account for the largest share of this
  market. The large share of the market is
  attributed to rising prevalence of diseases and
  increasing government and non-government
  initiatives for vaccine RD activities.
• Disease indications, included in the vaccines
  market are pneumococcal disease, influenza,
  diphtheria, tetanus, and pertussis (DTP),
  hepatitis, rotavirus, varicella, meningococcal
  disease, polio, measles, mumps, and rubella
  (MMR), human papilloma virus (HPV) infection, and
  others. The pneumococcal disease segment is
  expected to account for the largest share of the
  global market in 2016. High incidence of
  pneumococcal infections and the need for
  immunizations to prevent the disease increases
  the market growth of this segment.
• End-users, included in the vaccines market are
  paediatrics and adults. The paediatrics segment
  is expected to account for the largest share of
  the global market in 2016. Rising number of
  awareness programs to promote vaccination have
  resulted in the increasing use of vaccines for
  paediatrics.

4

• Market Segmentation
• This report categorizes the vaccines market into
  the following segments
• Vaccines Market, by Product
• Conjugate vaccines
• Live Attenuated vaccines
• Inactivated and Subunit Vaccines
• Toxoid vaccines
• Recombinant vaccines
• Available Customizations
• With the given market data, MarketsandMarkets
  offers customizations as per the companys
  specific needs. The following customization
  options are available for the report
• Company Information Detailed company profiles of
  five or more market players
• Opportunities Assessment A detailed report
  underlining the various growth opportunities
  presented in the market

5

• Geographically, the vaccines market is dominated
  by North America, followed by Europe, Asia, and
  the Rest of the World (RoW). Growth in the North
  American segment is primarily driven by
  government initiatives for immunization against
  diseases such as influenza and HPV in the North
  American countries.
• The major players in the vaccines market are
  Astellas Pharma Inc. (Japan), CSL Limited
  (Australia), Emergent BioSolutions, Inc. (U.S.),
  GlaxoSmithKline, plc. (U.K.), Johnson Johnson
  (U.S.), MedImmune, LLC (U.S.), Merck Co.
  (U.S.), Pfizer, Inc. (U.S.), Sanofi Pasteur
  (France), and Serum Institute of India Pvt. Ltd.
  (India).
• Request Knowledge Store Demo
• http//www.marketsandmarkets.com/Knowledgestore.as
  p

6
Contact Us
Mr. RohanMarkets and Markets UNIT no 802, Tower
no. 7, SEZ Magarpatta city, Hadapsar Pune,
Maharashtra 411013, IndiaEmail sales_at_marketsandm
arkets.com  http//twitter.com/marketsmarkets
http//www.linkedin.com/company/marketsandmarkets
7
About MarketsandMarkets
MarketsandMarkets is the worlds No. 2 firm in
terms of annually published premium market
research reports. Serving 1700 global fortune
enterprises with more than 1200 premium studies
in a year, MM is catering to a multitude of
clients across 8 different industrial verticals.
We specialize in consulting assignments and
business research across high growth markets,
cutting edge technologies and newer applications.
Our 850 fulltime analyst and SMEs at
MarketsandMarkets are tracking global high growth
markets following the "Growth Engagement Model
GEM". The GEM aims at proactive collaboration
with the clients to identify new opportunities,
identify most important customers, write "Attack,
avoid and defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MMs flagship competitive
intelligence and market research platform, "RT"
connects over 200,000 markets and entire value
chains for deeper understanding of the unmet
insights along with market sizing and forecasts
of niche markets. The new included chapters on
Methodology and Benchmarking presented with high
quality analytical infographics in our reports
gives complete visibility of how the numbers have
been arrived and defend the accuracy of the
numbers. We at MarketsandMarkets are inspired to
help our clients grow by providing apt business
insight with our huge market intelligence
repository.